FR2805266B1 - Compositions utilisables pour reguler l'activite de la parkine - Google Patents

Compositions utilisables pour reguler l'activite de la parkine

Info

Publication number
FR2805266B1
FR2805266B1 FR0001980A FR0001980A FR2805266B1 FR 2805266 B1 FR2805266 B1 FR 2805266B1 FR 0001980 A FR0001980 A FR 0001980A FR 0001980 A FR0001980 A FR 0001980A FR 2805266 B1 FR2805266 B1 FR 2805266B1
Authority
FR
France
Prior art keywords
compositions
controlling
parkin activity
parkin
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0001980A
Other languages
English (en)
French (fr)
Other versions
FR2805266A1 (fr
Inventor
Laurent Pradier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0001980A priority Critical patent/FR2805266B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to ES01907820T priority patent/ES2345318T3/es
Priority to MXPA02007869A priority patent/MXPA02007869A/es
Priority to DE60141948T priority patent/DE60141948D1/de
Priority to IL15121101A priority patent/IL151211A0/xx
Priority to CA2400256A priority patent/CA2400256C/fr
Priority to NZ520802A priority patent/NZ520802A/en
Priority to AT01907820T priority patent/ATE466083T1/de
Priority to BR0108376-7A priority patent/BR0108376A/pt
Priority to DK01907820.3T priority patent/DK1259606T3/da
Priority to KR1020027010630A priority patent/KR100811926B1/ko
Priority to PCT/FR2001/000461 priority patent/WO2001060857A2/fr
Priority to EP01907820A priority patent/EP1259606B1/fr
Priority to PT01907820T priority patent/PT1259606E/pt
Priority to AU2001235696A priority patent/AU2001235696A1/en
Priority to JP2001560240A priority patent/JP4861590B2/ja
Priority to US09/785,548 priority patent/US7132396B2/en
Publication of FR2805266A1 publication Critical patent/FR2805266A1/fr
Priority to IL151211A priority patent/IL151211A/en
Priority to ZA200206550A priority patent/ZA200206550B/en
Priority to NO20023914A priority patent/NO20023914L/no
Application granted granted Critical
Publication of FR2805266B1 publication Critical patent/FR2805266B1/fr
Priority to US11/390,195 priority patent/US8273548B2/en
Priority to IL193310A priority patent/IL193310A/en
Priority to CY20101100700T priority patent/CY1111004T1/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR0001980A 2000-02-17 2000-02-17 Compositions utilisables pour reguler l'activite de la parkine Expired - Fee Related FR2805266B1 (fr)

Priority Applications (23)

Application Number Priority Date Filing Date Title
FR0001980A FR2805266B1 (fr) 2000-02-17 2000-02-17 Compositions utilisables pour reguler l'activite de la parkine
PT01907820T PT1259606E (pt) 2000-02-17 2001-02-15 Composições utilizáveis para regular a actividade da parkina
DE60141948T DE60141948D1 (de) 2000-02-17 2001-02-15 Zur steuerung der parkinaktivität brauchbare zusammensetzungen
IL15121101A IL151211A0 (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity
CA2400256A CA2400256C (fr) 2000-02-17 2001-02-15 Compositions utilisables pour reguler l'activite de la parkine
NZ520802A NZ520802A (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity
AT01907820T ATE466083T1 (de) 2000-02-17 2001-02-15 Zur steuerung der parkinaktivität brauchbare zusammensetzungen
BR0108376-7A BR0108376A (pt) 2000-02-17 2001-02-15 Composto, polepeptìdeo, ácido nucleico, vetor, vìrus recombinante defectivo, anticorpo ou fragmento ou derivado de anticorpo, composição farmacêutica, processos para a seleção ou a caracterização de moléculas ativas e para a produção de um composto peptìdico, proteìna, célula, e, mamìfero não-humano
DK01907820.3T DK1259606T3 (da) 2000-02-17 2001-02-15 Sammensætninger, der er egnede til regulering af parkinaktivitet
MXPA02007869A MXPA02007869A (es) 2000-02-17 2001-02-15 Composiciones utiles para regular la actividad del gen de la parkina.
PCT/FR2001/000461 WO2001060857A2 (fr) 2000-02-17 2001-02-15 Compositions utilisables pour reguler l'activite de la parkine
JP2001560240A JP4861590B2 (ja) 2000-02-17 2001-02-15 パーキンの活性調節に有用な組成物
ES01907820T ES2345318T3 (es) 2000-02-17 2001-02-15 Composiciones utilizables para regular la actividad de la parquina.
AU2001235696A AU2001235696A1 (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity
EP01907820A EP1259606B1 (fr) 2000-02-17 2001-02-15 Compositions utilisables pour reguler l'activite de la parkine
KR1020027010630A KR100811926B1 (ko) 2000-02-17 2001-02-15 파킨 유전자 활성의 조절에 유용한 조성물
US09/785,548 US7132396B2 (en) 2000-02-17 2001-02-20 Compositions which can be used for regulating the activity of parkin
IL151211A IL151211A (en) 2000-02-17 2002-08-12 A polypeptide that interacts with the parkin gene, pharmacological compositions containing it for use in the treatment of neurodegenerative pathologies and a method for its preparation
ZA200206550A ZA200206550B (en) 2000-02-17 2002-08-15 Compositions useful for regulating parkin gene activity.
NO20023914A NO20023914L (no) 2000-02-17 2002-08-16 Preparater for anvendelse for regulering av aktiviteten til parkingenet
US11/390,195 US8273548B2 (en) 2000-02-17 2006-03-28 Nucleic acids encoding a human PAP1 polypeptide
IL193310A IL193310A (en) 2000-02-17 2008-08-07 An antibody against a polypeptide which reacts with Parkin and medicinal preparations containing it
CY20101100700T CY1111004T1 (el) 2000-02-17 2010-07-27 Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0001980A FR2805266B1 (fr) 2000-02-17 2000-02-17 Compositions utilisables pour reguler l'activite de la parkine

Publications (2)

Publication Number Publication Date
FR2805266A1 FR2805266A1 (fr) 2001-08-24
FR2805266B1 true FR2805266B1 (fr) 2004-12-03

Family

ID=8847103

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0001980A Expired - Fee Related FR2805266B1 (fr) 2000-02-17 2000-02-17 Compositions utilisables pour reguler l'activite de la parkine

Country Status (6)

Country Link
JP (1) JP4861590B2 (https=)
DK (1) DK1259606T3 (https=)
ES (1) ES2345318T3 (https=)
FR (1) FR2805266B1 (https=)
PT (1) PT1259606E (https=)
ZA (1) ZA200206550B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116254286B (zh) * 2022-12-23 2024-07-12 厦门大学 氰胺诱导的酿酒酵母工程菌及其构建方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2449501A (en) * 1999-12-21 2001-07-03 Incyte Genomics, Inc. Vesicle trafficking proteins

Also Published As

Publication number Publication date
ES2345318T3 (es) 2010-09-21
ZA200206550B (en) 2003-12-19
JP4861590B2 (ja) 2012-01-25
FR2805266A1 (fr) 2001-08-24
DK1259606T3 (da) 2010-08-23
JP2003523193A (ja) 2003-08-05
PT1259606E (pt) 2010-08-02

Similar Documents

Publication Publication Date Title
EP1263461A4 (en) ADENOVIRUS FORMULATIONS
DE69912223D1 (de) Methylmethacrylat-Zusammensetzung
PL360404A1 (pl) 3'-proleki 2'-dezoksy-beta-L-nukleozydów
FR12C0010I2 (fr) Composition herbicide
EP1346724A4 (en) AGENT FOR TREATING HEPATITIS C
EP1092755A4 (en) COATING COMPOSITION
ATE232364T1 (de) Zuckergusszusammensetzung
FR2785155B3 (fr) Structure d'element decoratif pour cheveux
DE19781549T1 (de) Desinfektionszusammensetzung "Weltolen"
FR2770408B1 (fr) Poignee pour catheter
EP1249482A4 (en) AEROSOL COMPOSITION
DE60015536D1 (de) Flüssige herbizidzusammensetzung
DE60126423D1 (de) Wasserlösliche fixierwachszusammensetzung
EP1153612A4 (en) Anticancer agent potentiators
DE60008839D1 (de) Duftstoff-Zusammensetzung
ID30054A (id) Komposisi deterjen densitas-tinggi
ITVE20010021U1 (it) "martinetto idraulico perfezionato"
FR2805266B1 (fr) Compositions utilisables pour reguler l'activite de la parkine
DE10080787D2 (de) Mikrobiozide Zusammensetzung
ITMI20011833A0 (it) Agenti che regolano la permeabilita' vascolare
DE60034215D1 (de) Oberflaechenaktive zusammensetzung
FR2814063B1 (fr) Composition cosmetique pour le soin des levres
FR2818131B1 (fr) Composition cosmetique comprenant de l'heparanase
FR2761059B1 (fr) Composition pour bouton d'allumettes
ITMI980071U1 (it) Autogru in particolare per l'inumazione dei feretri

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 16

ST Notification of lapse

Effective date: 20161028